December 2015 FDA Recall Pramipexole Dihydrochloride by Macleods Pharma Usa Inc
D-0653-2016 - Presence of Foreign Tablets/Capsules

This Class II drug recall was voluntarily initiated by Macleods Pharma Usa Inc on December 24, 2015 for the product Pramipexole Dihydrochloride. The FDA reported the reason for recall as presence of foreign tablets/capsules. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0653-2016

Reason for Recall
Presence of Foreign Tablets/Capsules: Presence of a comingled Carbimazole 5 mg tablet.
Initiated
12-24-2015
Reported
02-17-2016
Quantity
N/A

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Macleods Pharma Usa Inc
Pramipexole Dihydrochloride Tablets 0.125 mg, 90 Ct Bottles, Rx Only. Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals Ltd., Baddi, Himachal Pradesh, INDIA. NDC: 33342-031-10.

Batch or Lot Expiration Information

Lot# : BPA512A; Expiry: 06/2017.